Table 5.
Standardized incidence ratio (SIR) for malignancies developing at least 5 years following the first recorded cardiac catheterization (2 years for leukaemia and lymphoma)
| Disease | Observed | Expected3 | SIR [IQR] |
|---|---|---|---|
| All patients | |||
| All malignancies | 36 | 11.98 | 3.01 [2.09, 4.19] |
| Leukaemia | 4 | 2.31 | 1.73 [0.43, 4.53] |
| Lymphoma | 22 | 2.40 | 9.15 [5.66, 13.97] |
| Hodgkin lymphoma | 4 | 1.48 | 2.70 [0.68, 7.07] |
| Non-Hodgkin lymphoma | 18 | 0.92 | 19.49 [11.39, 31.10] |
| Central nervous system | 3 | 1.92 | 1.57 [0.28, 4.70] |
| After censoring post-transplant patients | |||
| All malignancies | 11 | 11.26 | 0.98 [0.48, 1.77] |
| Leukaemia | 4 | 2.22 | 1.80 [0.45, 4.71] |
| Lymphoma | 0 | 2.25 | – |
| Hodgkin lymphoma | 0 | 1.38 | – |
| Non-Hodgkin lymphoma | 0 | 0.87 | – |
| Central nervous system | 2 | 1.82 | 1.10 [0.09, 4.11] |
IQR interquartile range